About us

What StrategyLens is

StrategyLens publishes backtest evidence for individual stocks and ETFs. For each ticker it reports how a rules-based strategy would have performed across many historical market regimes, and states plainly what that evidence supports and what it does not.

It is operated by an individual sole trader based in the United Kingdom. It is a research tool, not a broker, an adviser or a signal service. You can reach us at info@strategylens.co.uk.

What the evidence actually is

Every figure on this site comes from backtests: a strategy applied to historical price data, measured over windows chosen to cover different market regimes. No figure on this site comes from money that was actually traded.

That distinction matters, and we would rather state it than let a chart imply otherwise. A backtest can tell you that a rule would have worked on the past it was measured on. It cannot tell you the rule will work next year, and the more variants you test the more likely one looks good by chance alone — which is why we report how many backtests sit behind each verdict, and why a thin one is labelled as thin rather than quietly shown alongside a thick one.

The methodology page sets out how the regimes are classified, how win rates are counted, and how risk levels are assigned.

What we tested that did not work

This is the part most sites leave out, so it is the part we lead with.

The strategy this project was built around is accumulation — buying into weakness on a rules-based schedule. We tested it properly and it did not clear the bar. A research assessment dated 5 September 2026 concluded that no demonstrated incremental profitability had been established over simply buying and holding. Both of the main variants we had expected to work, risky accumulation and pullback entry, returned negative.

Worse, and more usefully: while investigating why an early version had looked promising, we found three separate defects in our own statistical gates, each of which made a false positive more likely rather than less. They were fixed, and the results were re-run. The encouraging earlier numbers did not survive.

Several side investigations have also come back negative — cointegration-based pairs on two separate passes, and a GARCH volatility model. Those are recorded as negative results rather than quietly dropped.

We publish this because a research site that has never reported a negative result is telling you something about its standards rather than about the markets.

What this site is not

It is not financial advice, and nothing here is a personal recommendation. It does not know your circumstances, your tax position or your risk tolerance. Past performance, including simulated past performance, does not indicate future results, and you can lose money. If you want advice, speak to someone authorised to give it.

Legal

The terms covering use of this site, and what we do with your data:

Terms of service — What you agree to by using the site, and the limits of what it provides.

Privacy policy — What we collect, who processes it, and your rights under the UK GDPR.

Cookie policy — Analytics cookies only if you accept. What browser storage we use, and why.

Refund policy — There is no paid product yet. What would apply if one launches.